Goldman, Jennifer G. https://orcid.org/0000-0001-5014-7535
Boeve, Bradley F.
Armstrong, Melissa J.
Galasko, Doug R.
Galvin, James E.
Irwin, David J.
Leverenz, James B.
Marder, Karen
Abler, Victor
Biglan, Kevin
Irizarry, Michael C.
Keller, Bill
Lai, Robert
Munsie, Leanne
Belleville, Michael
Chaney, Ondrea
Richard, Ian
Taylor, Angela
Graham, Todd
Funding for this research was provided by:
Lewy Body Dementia Association
Article History
Received: 22 April 2021
Accepted: 23 June 2021
First Online: 8 July 2021
Declarations
:
: NA.
: NA.
: Goldman, JG receives research funding from Acadia, Michael J. Fox Foundation, and Parkinson’s Foundation. She has received honoraria from the International Parkinson and Movement Disorders Society, Medscape, Parkinson’s Foundation, and Parkinson’s Study Group. She serves as the director for the Lewy Body Dementia Association Research Center of Excellence.Boeve, B has served as an investigator for clinical trials sponsored by Biogen, Alector, and EIP Pharma. He serves on the Scientific Advisory Board of the Lewy Body Dementia Association, Association for Frontotemporal Degeneration, and Tau Consortium. He receives research support from the NIH, the Mayo Clinic Dorothy and Harry T. Mangurian Jr. Lewy Body Dementia Program, and the Little Family Foundation. He serves as the coordinating center director for the Lewy Body Dementia Association Research Center of Excellence.Armstrong, MJ is supported by grants from the NIA (P30AG047266, R01AG068128) and the Florida Department of Health (grant 20A08). She previously received compensation from the AAN for work as an evidence-based medicine methodology consultant and is on the level of evidence editorial board for Neurology® and related publications (uncompensated). She serves as an investigator for the Lewy Body Dementia Association Research Center of Excellence.Irwin, DJ is supported by grants from NINDS (NS109260), NIA (AG010124, U19-AG062418 P01-AG066597), and Penn Institute on Aging. He is an investigator for the Lewy Body Dementia Association Research Center of Excellence at Penn.Galasko, D receives research support from the NIH, State of California, Michael J. Fox Foundation, and the Alzheimer’s Drug Discovery Foundation. He is a consultant for Biogen, Amprion, Fujirebio, General Electric Healthcare, Generion, and Cognition Therapeutics and is the Editor-in-Chief of <i>Alzheimer’s Research & Therapy</i>.Galvin, JE serves on the Board of Directors for the Lewy Body Dementia Association, Lewy Body Resource Center, and the Southeast Florida Chapter of the Alzheimer Association; serves as a consultant for Biogen and Medivante-Prophase; performs clinical and cognitive evaluations in his clinical practice (15% effort) and bills for these procedures; is funded by NIH grants (R01 AG040211, R01 NS1010483, R01 AG057681, P30 AG059295, U01 NS100610, U54 AG063546, R01 AG056610, R01 AG054425, R01 AG056531, R01 AG040211, R01 NS1010483, R01 AG057681, P30 AG059295, U01 NS100610, U54 AG063546, R01 AG056610, R01 AG054425, and R01 AG056531) and by the Harry T. Mangurian Foundation and the Leo and Anne Albert Charitable Trust; and receives research support as director and principal investigator of the Lewy Body Dementia Research Center of Excellence from the Lewy Body Dementia Association.Leverenz, J has received grant/research funding from NIH (P30 AG062428, U01 NS100610, R01 AG022304, R01AG0577552, RF1AG051495, R21AG064271, P20AG068053), the Jane and Lee Seidman Endowed Chair for Advanced Neurological Research and Education, Douglas Herthel DVM Memorial Fund, and GE Healthcare and has received consultant fees from Biogen, Citibank, and Eisai. He serves as the director for the Cleveland Clinic Lewy Body Dementia Association Research Center of Excellence.Marder, K has received funding from NIH (NS100600 (MPI), U24NS107168 (MPI), UL1TR001873, NS095435, LM009886, MH230794), the Lewy Body Dementia Association, CHDI, Huntington’s Disease Society of America, Parkinson’s Disease Foundation, Michael J. Fox, and Springer LTD (section editor). She is a site investigator for Genentech, Triplet Therapeutics, and Prilenia.Abler, V is a full-time employee of Acadia Pharmaceuticals.Belleville, M declares that there are no competing interests.Biglan, K is a full-time employee and has a minor shareholder stake in Eli Lilly and Company.Irizarry, M is a full-time employee of Eisai, Inc.Keller, B is a full-time employee of Acadia Pharmaceuticals.Lai, R is an employee of Eisai.Munsie, L is full-time employee and has a minor shareholder stake in Eli Lilly and Company.Chaney, O is an employee of the Lewy Body Dementia Association.Richard, I is an employee of the Lewy Body Dementia Association.Taylor, A is an employee of the Lewy Body Dementia Association.Graham, T is an employee of the Lewy Body Dementia Association.